Tau Therapeutics, Xdynia deal

Tau Therapeutics and Xdynia merged to form Cavion LLC. In 2012, Tau launched Xdynia to develop calcium channel T-type inhibitors for neuropathic pain. Tau was developing calcium channel T-type antago...